-- China Resources Pharmaceutical (HKG:3320) unit China Resources Pharmaceutical Commercial Group completed the issue of 1.4 billion yuan of 1.65% corporate bonds in China maturing in three years, according to a Tuesday Hong Kong bourse filing.
The pharma firm intends to use proceeds for production expenditures, including the replenishment of working capital, repayment of debt, and project investments.